Mechanisms of Cardiomyocyte Proliferation and Differentiation in Development and Regeneration

Jessie Wettig Yester1, Bernhard Kühn2

  • 1Children's Hospital of Pittsburgh of UPMC, Department of Pediatrics, University of Pittsburgh School of Medicine, 4401 Penn Ave, Pittsburgh, PA, 15224-1334, USA.

Current Cardiology Reports
|February 11, 2017
PubMed

Insights

Cardiomyocyte proliferation continues into adulthood, with identified regulators offering potential therapeutic targets for heart disease. Further research and pre-clinical models are crucial for developing these regenerative strategies.

Area of Science:

  • Cardiovascular Biology
  • Regenerative Medicine
  • Molecular Cardiology

Background:

  • Congenital heart disease is the most common birth defect, while acquired heart disease is a leading cause of adult mortality.
  • Understanding cardiomyocyte proliferation and differentiation is key to addressing cardiac pathologies like heart failure and myocardial infarction.

Purpose of the Study:

  • To review signal transduction pathways and molecular mechanisms governing cardiomyocyte proliferation, differentiation, and regeneration.
  • To explore the potential of cardiomyocyte regeneration for treating cardiac diseases.

Main Methods:

  • Literature review of studies on cardiomyocyte proliferation and regeneration.
  • Analysis of identified regulators including cell cycle proteins, neuregulin, epigenetic factors, reactive oxygen species, and microRNAs.

Main Results:

  • Evidence supports ongoing cardiomyocyte proliferation in adult hearts.
  • Key regulators of cardiomyocyte proliferation and regeneration have been identified.

Conclusions:

  • Validated knowledge of cardiomyocyte regeneration can inform the development of therapeutic targets.
  • Standardized pre-clinical models are essential for advancing cardiomyocyte regeneration research and clinical application.
Abstract

Related Concept Videos

Structure of Cardiac Muscles01:13

Structure of Cardiac Muscles

Cardiac muscle, or myocardium, is a specialized type of muscle found exclusively in the heart. Its unique structural and functional characteristics enable the heart to perform its vital role of pumping blood throughout the body continuously and rhythmically. The cardiac muscle cells, or cardiomyocytes, possess an endomysium and perimysium but do not have an epimysium.
Compared to skeletal muscles, cardiac muscle cells are small and mostly have a single nucleus. Additionally, they are usually...
18.4K
Tissue Renewal without Stem Cells01:23

Tissue Renewal without Stem Cells

After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...
2.2K
Cellular Differentiation00:57

Cellular Differentiation

How does a complex organism such as a human develop from a single cell? It all starts from a single fertilized egg which gives rise to a vast array of cell types, such as nerve cells, muscle cells, and epithelial cells that characterize the adult? Throughout development and adulthood, cellular differentiation leads cells to assume their final morphology and physiology. Differentiation is the process by which unspecialized cells become specialized to carry out distinct functions.
A zygote is a...
6.0K
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.2K